Welcome to the Desert Angels™. We are a Tucson, Arizona based non-profit organization of accredited investors who seek opportunities to invest in Southwest regional startup or early stage companies. The organization serves as a forum for its over 100 members, who invest individually from their personal funds. Since 2000, Desert Angel members have invested over $29 million in more than 70 presenting companies.

Tucson Drug Startups in Key Clinical Trials

by gabrielsayegh on October 12th, 2014 at 10:53pm

Desert Angels portfolio companies, Cancer Prevention Pharmacuticals (CPP) & NuvOx Pharma (NuvOx), are in human clinical trials that could result in new drug approvals in the next few years. Both of these local startup companies are founded by University of Arizona research faculty. Local biosciences industry leaders say the companies’ progress in navigating the long and costly drug-approval process is noteworthy, as they progress through trials at the same time.

Click here for the full article

Comment

Filed under: Uncategorized

HTG Molecular Diagnostics Announces $16 Million Term Loan Agreement With Silicon Valley Bank and Oxford Finance

by gabrielsayegh on August 30th, 2014 at 8:41pm

Desert Angels portfolio company, HTG Molecular Diagnostics, announced that it has closed a growth capital term loan facility with Silicon Valley Bank and Oxford Finance. The loan facility provides HTG with up to $16 million of available proceeds, with $11 million funded at the initial closing this month.

For More: HTG Molecular Diagnostics Announces $16 Million Term Loan Agreement With Silicon Valley Bank and Oxford Finance

Comment

Gaming for good—with celebrities

by gabrielsayegh on August 30th, 2014 at 8:34pm

Fortune Magazine reported that Desert Angels portfolio company, Tiltify, capitalizes on livestreaming and opens up opportunities for celebrities, athletes and gamers to play for good causes.

For more: Gaming for good—with celebrities

Comment

Filed under: Funded Companies

Ranking Angel Investment Groups

by chrismarin on August 30th, 2014 at 8:30pm

Desert Angels is ranked among the top 20 angel investment groups of over 350 screened by CB Insights.

For more: Ranking Angel Investment Groups

Comment

Filed under: Press

Stem cell therapy could lead to HIV cure

by chrismarin on August 7th, 2014 at 4:03pm

Desert Angels portfolio company Calimmune is recognized for being at the forefont of developing a practical cure for people living with HIV infection.

Special note: The article erroneously credits the company as a San Diego based company – Calimmune is a Tucson based company.

For more: Stem cell therapy could lead to HIV cure

Comment

Filed under: Funded Companies, Press

NuvOx announces Phase Ib trial for Glioblastoma and additional NIH funding

by chrismarin on August 7th, 2014 at 3:42pm

NuvOx Pharma, a privately held biotechnology company based in Tucson, Arizona, announced that on July 14th, it began a Phase Ib clinical trial of its new drug NVX-108 in patients with glioblastoma, a deadly form of brain cancer.

For more: NuvOx announces Phase Ib trial for Glioblastoma and additional NIH funding

1 comment

Filed under: News Releases, Press

Contatta’s collaborative email now available for free public beta testing

by chrismarin on August 6th, 2014 at 12:17am

Contatta, the Scottsdale-based creator of the email application, announced Monday it is now free for anyone who wants to sign up online. It will become a paid service in the fall. Contatta is designed to address four common problems: collaboration and discussions with others, task management, contact management and keeping files handy.

For more: Contatta’s collaborative email now available for free public beta testing

Comment

Filed under: Funded Companies, Press

One of the best ways to become an angel investor in early-stage private companies is to join a local angel group.

by Curtis Gunn on July 28th, 2014 at 4:26pm

A very good article from David Rose (founder and Chair Emeritus of New York Angels) regarding the value that can come from joining a formal angel group.

The benefits of joining a [angel] group include pooling deal flow and capital, domain expertise, and investing experience. Most groups run regular education sessions for new members and provide mentoring for less-experienced investors.

Full Article on Marketwatch.

Comment

Filed under: Uncategorized

Calimmune Approved to Treat Second Group in HIV Stem Cell Gene Modification Study

by Curtis Gunn on July 21st, 2014 at 5:26pm

Calimmune today announced encouraging safety data from its innovative gene-based stem cell therapy, Cal-1-being developed to help cure individuals infected with HIV. The company can now begin treating the second group of patients in the trial, which is being funded in part by a grant from the California Institute for Regenerative Medicine (CIRM).

Link to Full Article.

1 comment

HTG receives US patent for HTG EdgeSeq chemistry

by Curtis Gunn on July 21st, 2014 at 5:18pm

HTG Molecular Diagnostics, a provider of instruments and reagents for translational research and molecular diagnostics, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,741,564 claiming a method for using quantitative nuclease protection technology in combination with next-generation-sequencing.

Link to Full Article.

Comment